Clinical Trial

PRIMA EU Retrospective & Prospective

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical study aims at evaluating clinical, radiographic and patient-reported outcomes after total anatomic or reverse shoulder replacement using PRIMA humeral stem up to 24 months after surgery, in order to assess the short-term performance of the implant. Furthermore, the objective is also to collect short-term data on the survivorship of the implant and the incidence of complications.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12 -> 2030-01 2026-08-13
minor Completion pushed: 2026-12 -> 2030-01 2026-08-13
Trial Details
NCT Number NCT06371833
Lead Sponsor Limacorporate S.p.a
Conditions Arthroplasty, Replacement, Shoulder
Enrollment 60 participants
Start Date 2024-10-25
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12